Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models
作者： Anand Giddabasappa , Kush Lalwani , Rand Norberg , Hovhannes J. Gukasyan , David Paterson
DOI: 10.1016/J.EXER.2016.02.010
关键词: Platelet-derived growth factor 、 Cancer research 、 In vivo 、 Axitinib 、 Macular degeneration 、 Tyrosine-kinase inhibitor 、 Choroidal neovascularization 、 Neovascularization 、 Internal medicine 、 Platelet-derived growth factor receptor 、 Endocrinology 、 Medicine 、 Ophthalmology 、 Sensory Systems 、 Cellular and Molecular Neuroscience
摘要: … Automatic quantitation of tube length was performed using … of axitinib alone significantly reduced 3D sprout formation. This … and manuscript was provided by Pfizer Inc. All authors are …
elsevier.com
core.ac.uk 
sci-hub.se 参考文章(36)
K. K. Hirschi, P. A.` D’Amore, Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS. ,vol. 79, pp. 419- 428 ,(1997) , 10.1007/978-3-0348-9006-9_18
Diane C. Darland, Patricia A. D'Amore, Cell-cell interactions in vascular development. Current Topics in Developmental Biology. ,vol. 52, pp. 107- 149 ,(2001) , 10.1016/S0070-2153(01)52010-4
FARZIN FOROOGHIAN, CATHERINE CUKRAS, CATHERINE B. MEYERLE, EMILY Y. CHEW, WAI T. WONG, Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 29, pp. 723- 731 ,(2009) , 10.1097/IAE.0B013E3181A2C1C3
Rebecca G. Bagley, William Weber, Cecile Rouleau, Beverly A. Teicher, Pericytes and Endothelial Precursor Cells: Cellular Interactions and Contributions to Malignancy Cancer Research. ,vol. 65, pp. 9741- 9750 ,(2005) , 10.1158/0008-5472.CAN-04-4337
Seungbum Kang, Young-Jung Roh, In-Beom Kim, Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice. Experimental Eye Research. ,vol. 112, pp. 125- 133 ,(2013) , 10.1016/J.EXER.2013.05.006
Francesco Semeraro, Morescalchi, Sarah Duse, Francesco Parmeggiani, Gambicorti, Ciro Costagliola, Aflibercept in wet AMD: specific role and optimal use Drug Design Development and Therapy. ,vol. 7, pp. 711- 722 ,(2013) , 10.2147/DDDT.S40215
Nobuo Jo, Carolina Mailhos, Meihua Ju, Eunice Cheung, John Bradley, Kazuaki Nishijima, Gregory S. Robinson, Anthony P. Adamis, David T. Shima, Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization The American Journal of Pathology. ,vol. 168, pp. 2036- 2053 ,(2006) , 10.2353/AJPATH.2006.050588
Ying Chen, Michael A. Tortorici, May Garrett, Brian Hee, Karen J. Klamerus, Yazdi K. Pithavala, Clinical Pharmacology of Axitinib Clinical Pharmacokinectics. ,vol. 52, pp. 713- 725 ,(2013) , 10.1007/S40262-013-0068-3
Michael Stewart, Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clinical Ophthalmology. ,vol. 6, pp. 1175- 1186 ,(2012) , 10.2147/OPTH.S33372
Jayakrishna Ambati, Benjamin J Fowler, None, Mechanisms of age-related macular degeneration Neuron. ,vol. 75, pp. 26- 39 ,(2012) , 10.1016/J.NEURON.2012.06.018